Insulin Susp Isophane Semisynthetic Purified Human

CHEMBL1201627 Phase 4 承認済み Protein
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

A semisynthetic intermediate-acting insulin suspension formulated with protamine to slow its absorption and provide sustained blood sugar control. It is derived from pork insulin that has been chemically converted to match the human insulin sequence.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A semisynthetic intermediate-acting insulin suspension formulated with protamine to slow its absorption and provide sustained blood sugar control. It is derived from pork insulin that has been chemically converted to match the human insulin sequence.

Yes, Insulin Susp Isophane Semisynthetic Purified Human is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201627. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.